InspireMD receives Nasdaq delisting notice for bid price non-compliance

InspireMD, Inc.

Nasdaq notified InspireMD on July 17, 2026 that its common stock failed to maintain minimum $1.00 bid price for 30 consecutive business days.
Company has 180 calendar days, until January 13, 2027, to regain compliance by closing at $1.00+ for at least 10 consecutive business days.
If not cured, InspireMD may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure.
Options to regain compliance include a reverse stock split; no assurance of success is given.
Trading under symbol NSPR continues on Nasdaq Capital Market during the compliance period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.